Valuation Astal Laboratories Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 14:00:52 18/06/2026 +04			5-day change	1st Jan Change
83.95 ^INR	+3.16%		+12.13%	-3.34%

05-30	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-14	Astal Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	36.52	34.77	64.34	118.1	401.9	747.2
Change	-	-4.79%	85.03%	83.54%	240.29%	85.93%
Enterprise Value (EV) ¹	36.38	34.46	64.16	117.2	344.2	862.6
Change	-	-5.27%	86.18%	82.75%	193.57%	150.59%
P/E	-130x	577x	-376x	722x	26.3x	9.45x
PBR	0.71x	0.67x	1.25x	2.27x	1.72x	2.08x
PEG	-	-5x	1x	-4x	0x	0x
Capitalization / Revenue	18.1x	17.2x	30.5x	3.27x	1.7x	1.17x
EV / Revenue	18x	17.1x	30.4x	3.25x	1.45x	1.36x
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-	-	-	-	-	-
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0708	0.0152	-0.0431	0.041	1.554	8.043
Distribution rate	-	-	-	-	-	-
Net sales ¹	2.019	2.019	2.108	36.07	236.6	636.6
EBITDA	-	-	-	-	-	-
EBIT	-	-	-	-	-	-
Net income ¹	-0.2815	0.0602	-0.1711	0.164	7.847	89.25
Net Debt ¹	-0.1448	-0.3129	-0.1828	-0.844	-57.64	115.4
Reference price ²	9.19	8.75	16.19	29.60	40.88	76.01
Nbr of stocks (in thousands)	3,974	3,974	3,974	3,990	9,830	9,830
Announcement Date	10/09/20	01/09/21	08/09/22	25/08/23	12/07/24	18/08/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASTAL LABORATORIES LIMITED	-	-	-	-	37.67M
ELI LILLY AND COMPANY	32.54x	11.83x	24.36x	0.61%	992B
JOHNSON & JOHNSON	25.03x	5.77x	15.69x	2.28%	564B
ABBVIE INC.	27.45x	6.62x	13.53x	3.1%	391B
ROCHE HOLDING AG	17.47x	4.34x	10.68x	3.06%	330B
ASTRAZENECA PLC	22.62x	4.72x	13.39x	1.85%	280B
NOVARTIS AG	21.12x	5.46x	13.25x	2.94%	279B
NOVO NORDISK A/S	12.67x	4.72x	9.72x	3.98%	196B
AMGEN INC.	22.21x	5.97x	10.43x	2.95%	184B
GILEAD SCIENCES, INC.	-44.95x	5.42x	29.92x	2.59%	156B
Average	15.13x	6.10x	15.66x	2.59%	337.13B
Weighted average by Cap.	22.15x	7.33x	17.13x	2.13%